View in EDS

Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.

Saved in:
Bibliographic Details
Title: Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Authors: Connor MP; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: matthew.connor@pennmedicine.upenn.edu., Loren AW; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Hexner EO; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Martin ME; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Gill SI; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Luger SM; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Mangan JK; Moores Cancer Center at the University of California, San Diego, California., Perl AE; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., McCurdy SR; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Pratz KW; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Timlin C; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Freyer CW; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Carulli A; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Catania C; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Smith J; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Hollander L; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Zebrowski AM; Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Stadtmauer EA; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Porter DL; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Frey NV; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Feb; Vol. 29 (2), pp. 113-118. Date of Electronic Publication: 2022 Nov 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36336258
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Connor+MP%22">Connor MP</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: matthew.connor@pennmedicine.upenn.edu.<br /><searchLink fieldCode="AU" term="%22Loren+AW%22">Loren AW</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hexner+EO%22">Hexner EO</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Martin+ME%22">Martin ME</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Gill+SI%22">Gill SI</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Luger+SM%22">Luger SM</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Mangan+JK%22">Mangan JK</searchLink>; Moores Cancer Center at the University of California, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Perl+AE%22">Perl AE</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22McCurdy+SR%22">McCurdy SR</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Pratz+KW%22">Pratz KW</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Timlin+C%22">Timlin C</searchLink>; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Freyer+CW%22">Freyer CW</searchLink>; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Carulli+A%22">Carulli A</searchLink>; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Catania+C%22">Catania C</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Smith+J%22">Smith J</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hollander+L%22">Hollander L</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Zebrowski+AM%22">Zebrowski AM</searchLink>; Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Stadtmauer+EA%22">Stadtmauer EA</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Porter+DL%22">Porter DL</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Frey+NV%22">Frey NV</searchLink>; Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2023 Feb; Vol. 29 (2), pp. 113-118. <i>Date of Electronic Publication: </i>2022 Nov 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36336258
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtct.2022.10.027
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 113
    Titles:
      – TitleFull: Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Connor MP
      – PersonEntity:
          Name:
            NameFull: Loren AW
      – PersonEntity:
          Name:
            NameFull: Hexner EO
      – PersonEntity:
          Name:
            NameFull: Martin ME
      – PersonEntity:
          Name:
            NameFull: Gill SI
      – PersonEntity:
          Name:
            NameFull: Luger SM
      – PersonEntity:
          Name:
            NameFull: Mangan JK
      – PersonEntity:
          Name:
            NameFull: Perl AE
      – PersonEntity:
          Name:
            NameFull: McCurdy SR
      – PersonEntity:
          Name:
            NameFull: Pratz KW
      – PersonEntity:
          Name:
            NameFull: Timlin C
      – PersonEntity:
          Name:
            NameFull: Freyer CW
      – PersonEntity:
          Name:
            NameFull: Carulli A
      – PersonEntity:
          Name:
            NameFull: Catania C
      – PersonEntity:
          Name:
            NameFull: Smith J
      – PersonEntity:
          Name:
            NameFull: Hollander L
      – PersonEntity:
          Name:
            NameFull: Zebrowski AM
      – PersonEntity:
          Name:
            NameFull: Stadtmauer EA
      – PersonEntity:
          Name:
            NameFull: Porter DL
      – PersonEntity:
          Name:
            NameFull: Frey NV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2023 Feb
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6367
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Transplantation and cellular therapy
              Type: main
ResultId 1